Allocate Software (LSE:ALLA) Research & Development: £8.33 Mil (TTM As of May. 2014)


What is Allocate Software Research & Development?

Allocate Software LSE:ALLA Research & Development is £8.33 Mil as of May. 2014. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Allocate Software's Research & Development for the six months ended in May. 2014 was £4.20 Mil. Its Research & Development for the trailing twelve months (TTM) ended in May. 2014 was £8.33 Mil.

Allocate Software  (LSE:ALLA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Allocate Software Research & Development Related Terms

Allocate Software Research & Development Historical Data

* Premium members only.

The historical data trend for Allocate Software's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allocate Software Research & Development Chart

Allocate Software Annual Data
Trend May05 May06 May07 May08 May09 May10 May11 May12 May13 May14
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 4.56 6.79 7.48 8.33

Allocate Software Semi-Annual Data
Nov04 May05 Nov05 May06 Nov06 May07 Nov07 May08 Nov08 May09 Nov09 May10 Nov10 May11 Nov11 May12 Nov12 May13 Nov13 May14
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.38 3.77 3.72 4.13 4.20

Allocate Software Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in May. 2014 adds up the semi-annually data reported by the company within the most recent 12 months, which was £8.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £8.33 Mil mean?
Allocate Software (LSE:ALLA) has a Research & Development of £8.33 Mil as of May. 2014. Research and development expense is the total cost for research and development activities. View historical data on Allocate Software and its competitors.
Is Allocate Software's Research & Development too high?
Allocate Software's current Research & Development is £8.33 Mil.
How does Allocate Software's Research & Development compare to SREV and ASUR?
Allocate Software's Research & Development of £8.33 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Allocate Software and its competitors. Allocate Software's current Research & Development is £8.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allocate Software stock overvalued right now?
Allocate Software (LSE:ALLA) has a current Research & Development of £8.33 Mil. The current Research & Development is £8.33 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Allocate Software (LSE:ALLA), the current Research & Development is £8.33 Mil as of May. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Allocate Software Business Description

Allocate Software PLC is engaged in the development, sale and support of workforce management solutions, and the provision of related IT services to major healthcare, defence, government and commercial customers. The business of the company is focused principally on the Healthcare market in addition to Defence. Its segments are Licence, Subscriptions, Support, and Services. Licence and Subscriptions segments represent the sale of non-cancellable software licence agreements and subscriptions associated with that software. Support and Services segments represent the provision of installation, consulting, training and product support. It operates in UK, Europe, USA and Australia.